ASCO 2027 exhibitors

Jun 4–8, 2027 Chicago, IL ~44k attendees Website

296 organizations exhibit at ASCO 2027 — 139 diagnostics, technology and service companies, 88 drug developers and 69 advocacy groups, societies, cancer centers, publishers and agencies. 296 of them have their own page in this guide. As of Oct 8, 2026.

All 296 organizations at ASCO 2027 →

Focus
Showing 1–30 of 296 organizations
OrganizationASCO 2027 Attendance
1Cell.Ai
Cupertino, CA
Diagnostics companies
Single-cell multi-omics testing of live circulating tumor cells from blood, with AI models that predict homologous recombination deficiency.
Booth
Exhibiting at Booth 24016
AbbVie
North Chicago, IL
Pharmaceutical companies3 exhibitor meeting rooms
Global drugmaker whose cancer medicines include venetoclax and ibrutinib for blood cancers and the ADC mirvetuximab soravtansine for ovarian cancer.
Booth
Exhibiting at Booth 27033
Accord BioPharma
Raleigh, NC
Biotech companies
Specialty arm of the Intas group marketing the prostate cancer drug Camcevi, lenalidomide, and supportive-care biosimilars such as filgrastim and pegfilgrastim.
Booth
Exhibiting at Booth 37073
Acrotech Biopharma
East Windsor, NJ
Biotech companies
Specialty drug company commercializing approved cancer medicines in the US, including treatments for T-cell lymphoma.
Booth
Exhibiting at Booth 10092
Diagnostics companies
Immune-sequencing company whose clonoSEQ test measures minimal residual disease in myeloma, leukemia and lymphoma.
Booth
Exhibiting at Booth 17151
Advanced Clinical
Deerfield, IL
Clinical research organizations
Clinical development partner offering CRO, functional service provider and staffing services from early-phase research to commercialization.
Booth
Exhibiting at Booth IH05
Advanced CTS
Somerset, NJ
Service providers
FDA-registered drug wholesaler providing clinical trial supply services: comparator sourcing, import and export, and drug depot storage.
Booth
Exhibiting at Booth 35142
Agendia
Irvine, CA
Diagnostics companies
Breast cancer genomics company whose MammaPrint and BluePrint tests gauge recurrence risk and tumor subtype to guide early-stage treatment.
Booth
Exhibiting at Booth 27147
Agilent Technologies
Santa Clara, CA
Diagnostics companies
Laboratory technology company whose clinical offerings include pathology staining systems, PD-L1 companion diagnostics and genomic assays for cancer testing.
Booth
Exhibiting at Booth 13149
Aignostics
Berlin, Germany
Health technology companies
AI pathology company analyzing tissue images and multimodal data for biopharma, from target discovery to trials and companion diagnostics.
Booth
Exhibiting at Booth IH15
Akeso
Zhongshan City, China
Biotech companies
Chinese antibody drugmaker with bispecific immunotherapies, including the PD-1/VEGF antibody ivonescimab for lung cancer.
Booth
Exhibiting at Booth 37147
Allucent
Cary, NC
Clinical research organizations
Contract research organization running oncology and hematology trials for small and mid-size biopharma, from preclinical work to Phase IV.
Booth
Exhibiting at Booth 27036
Almac
Craigavon, UK
Diagnostics companies
Diagnostic services unit of the Almac group, running biomarker and companion diagnostic development, multi-omic analysis and clinical testing for drug trials.
Booth
Exhibiting at Booth 15157
ALX Oncology
South San Francisco, CA
Biotech companies
Clinical-stage immuno-oncology biotech developing evorpacept, a CD47 blocker, with positive data in HER2-positive gastric cancer.
Booth
Exhibiting at Booth IH09
Professional societies
Professional society of hematologists supporting research, education and advocacy on blood diseases, with meetings, journals and awards.
Booth
Exhibiting at Booth 10024
Amgen
Thousand Oaks, CA
Pharmaceutical companies2 exhibitor meeting rooms
Biotechnology drugmaker with cancer medicines for lung, blood and colorectal cancers, including targeted therapies and bispecific T-cell engagers.
Booth
Exhibiting at Booth 22025
Amoy Diagnostics
Xiamen, China
Diagnostics companies
Chinese maker of PCR and sequencing kits that detect tumor gene mutations, including companion diagnostics widely used in lung cancer.
Booth
Exhibiting at Booth 22114
AplusA
Lyon, France
Health technology companies
French healthcare research company that collects real-world prescribing and patient data worldwide and turns it into insights for drugmakers.
Booth
Exhibiting at Booth 14156
Biotech companies
Clinical-stage biotech with registrational programs in kidney cancer (HIF-2α inhibitor casdatifan) and pancreatic cancer (CD73 inhibitor quemliclustat).
Booth
Exhibiting at Booth 32146
Arima Genomics
Orlando, FL
Diagnostics companies
Genomics company whose CLIA lab tests tumors using whole-genome sequencing plus 3D genome structure; also sells research kits and software.
Booth
Exhibiting at Booth 10082
Ascentage Pharma
Suzhou, China
Biotech companies
Drug developer focused on blood cancers, with the TKI olverembatinib and the Bcl-2 inhibitor lisaftoclax among its programs.
Booth
Exhibiting at Booth 37103
Astellas
Tokyo, Japan
Pharmaceutical companies
Japanese drugmaker with cancer medicines including enzalutamide for prostate cancer, enfortumab vedotin for bladder cancer and zolbetuximab for gastric cancer.
Booth
Exhibiting at Booth 15117
AstraZeneca
Cambridge, UK
Pharmaceutical companies50 exhibitor meeting rooms
Global drugmaker with cancer medicines across lung, breast, blood and other cancers, including targeted therapies, immunotherapy and ADCs.
Booth
Exhibiting at Booth 19029
AVEO Oncology
Boston, MA
Biotech companies
Oncology company, owned by LG Chem, that markets the kidney cancer drug tivozanib (Fotivda) in the US.
Booth
Exhibiting at Booth 19023
Bayer
Leverkusen, Germany
Pharmaceutical companies5 exhibitor meeting rooms
Global drugmaker whose cancer medicines include darolutamide and radium-223 for prostate cancer and regorafenib for colorectal and liver cancers.
Booth
Exhibiting at Booth 13059
BeOne Medicines
Basel, Switzerland
Pharmaceutical companies5 exhibitor meeting rooms
Global oncology company, formerly BeiGene, marketing zanubrutinib for blood cancers and the PD-1 antibody tislelizumab.
Booth
Exhibiting at Booth 24021, 24033
Diagnostics companies
Oncology testing arm of BillionToOne, using single-molecule counting NGS for liquid biopsy therapy selection and treatment response monitoring.
Booth
Exhibiting at Booth 10071
Biocartis
Mechelen, Belgium
Diagnostics companies
Maker of the Idylla automated PCR system for rapid molecular testing of tumor samples to guide treatment.
Booth
Exhibiting at Booth 37075
Biodesix
Louisville, CO
Diagnostics companies
Diagnostics company with blood-based lung cancer tests, plus development services for biopharma diagnostic and drug programs.
Booth
Exhibiting at Booth 30099
BioNTech
Mainz, Germany
Biotech companies2 exhibitor meeting rooms
Immunotherapy company developing mRNA cancer vaccines, a PD-L1/VEGF bispecific antibody, antibody-drug conjugates and CAR-T cell therapies.
Booth
Exhibiting at Booth 24103

Explore the full ASCO 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Chicago. Leave your work email and we’ll be in touch.

Privacy

Download the full ASCO 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ASCO 2027 exhibitors

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse ASCO 2027 by

Exhibit hall
  • Exhibitors 296

Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction